Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)

Bayer · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
carcinomahepatocellular-carcinoma
carcinoma, hepatocellular, hepatocellular carcinoma, mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor, objective tumor response rate (orr), modified recist criteria, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 883544
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.